Similar articles for PMID: 16720928

Year	Number of Results
1993	1
1995	1
1996	3
1997	5
1998	13
1999	4
2000	21
2001	10
2002	21
2003	26
2004	19
2005	10
2006	14
2007	10
2008	6
2009	7
2010	12
2011	16
2012	12
2013	15
2014	6
2015	5
2016	12
2017	9
2018	18
2019	15
2020	18
2021	13
2022	6
2023	4
2024	0

1

Dendritic cells, pulsed with lysate of allogeneic tumor cells, are capable of stimulating MHC-restricted antigen-specific antitumor T cells.

Mahdian R, Kokhaei P, Najar HM, Derkow K, Choudhury A, Mellstedt H. Mahdian R, et al. Med Oncol. 2006;23(2):273-82. doi: 10.1385/MO:23:2:273. Med Oncol. 2006. PMID: 16720928

2

Tumor cell lysate-pulsed human dendritic cells induce a T-cell response against pancreatic carcinoma cells: an in vitro model for the assessment of tumor vaccines.

Schnurr M, Galambos P, Scholz C, Then F, Dauer M, Endres S, Eigler A. Schnurr M, et al. Cancer Res. 2001 Sep 1;61(17):6445-50. Cancer Res. 2001. PMID: 11522639

3

Analysis and characterization of antitumor T-cell response after administration of dendritic cells loaded with allogeneic tumor lysate to metastatic melanoma patients.

Bercovici N, Haicheur N, Massicard S, Vernel-Pauillac F, Adotevi O, Landais D, Gorin I, Robert C, Prince HM, Grob JJ, Leccia MT, Lesimple T, Wijdenes J, Bartholeyns J, Fridman WH, Salcedo M, Ferries E, Tartour E. Bercovici N, et al. J Immunother. 2008 Jan;31(1):101-12. doi: 10.1097/CJI.0b013e318159f5ba. J Immunother. 2008. PMID: 18157017 Clinical Trial.

4

Melanoma-reactive class I-restricted cytotoxic T cell clones are stimulated by dendritic cells loaded with synthetic peptides, but fail to respond to dendritic cells pulsed with melanoma-derived heat shock proteins in vitro.

Fleischer K, Schmidt B, Kastenmüller W, Busch DH, Drexler I, Sutter G, Heike M, Peschel C, Bernhard H. Fleischer K, et al. J Immunol. 2004 Jan 1;172(1):162-9. doi: 10.4049/jimmunol.172.1.162. J Immunol. 2004. PMID: 14688322

5

Novel approach to the characterization of melanoma associated-peptide-specific CTL lines from Japanese metastatic melanoma patients.

Akiyama Y, Maruyama K, Tai S, Takikawa M, Ohshita C, Yamamoto A, Yamazaki N, Kiyohara Y, Yamaguchi K. Akiyama Y, et al. Int J Oncol. 2008 Sep;33(3):433-41. Int J Oncol. 2008. PMID: 18695871

6

Human dendritic cells, pulsed with either melanoma tumor cell lysates or the gp100 peptide(280-288), induce pairs of T-cell cultures with similar phenotype and lytic activity.

Abdel-Wahab Z, DeMatos P, Hester D, Dong XD, Seigler HF. Abdel-Wahab Z, et al. Cell Immunol. 1998 May 25;186(1):63-74. doi: 10.1006/cimm.1998.1298. Cell Immunol. 1998. PMID: 9637766

7

Dendritic cell immunizations alone or combined with low doses of interleukin-2 induce specific immune responses in melanoma patients.

Escobar A, López M, Serrano A, Ramirez M, Pérez C, Aguirre A, González R, Alfaro J, Larrondo M, Fodor M, Ferrada C, Salazar-Onfray F. Escobar A, et al. Clin Exp Immunol. 2005 Dec;142(3):555-68. doi: 10.1111/j.1365-2249.2005.02948.x. Clin Exp Immunol. 2005. PMID: 16297169 Free PMC article. Clinical Trial.

8

Exosomes as potent cell-free peptide-based vaccine. I. Dendritic cell-derived exosomes transfer functional MHC class I/peptide complexes to dendritic cells.

André F, Chaput N, Schartz NE, Flament C, Aubert N, Bernard J, Lemonnier F, Raposo G, Escudier B, Hsu DH, Tursz T, Amigorena S, Angevin E, Zitvogel L. André F, et al. J Immunol. 2004 Feb 15;172(4):2126-36. doi: 10.4049/jimmunol.172.4.2126. J Immunol. 2004. PMID: 14764678

9

Targeting CD4(+) T-helper cells improves the induction of antitumor responses in dendritic cell-based vaccination.

Aarntzen EH, De Vries IJ, Lesterhuis WJ, Schuurhuis D, Jacobs JF, Bol K, Schreibelt G, Mus R, De Wilt JH, Haanen JB, Schadendorf D, Croockewit A, Blokx WA, Van Rossum MM, Kwok WW, Adema GJ, Punt CJ, Figdor CG. Aarntzen EH, et al. Cancer Res. 2013 Jan 1;73(1):19-29. doi: 10.1158/0008-5472.CAN-12-1127. Epub 2012 Oct 18. Cancer Res. 2013. PMID: 23087058 Clinical Trial.

10

Eliciting cytotoxic T lymphocytes against acute myeloid leukemia-derived antigens: evaluation of dendritic cell-leukemia cell hybrids and other antigen-loading strategies for dendritic cell-based vaccination.

Galea-Lauri J, Darling D, Mufti G, Harrison P, Farzaneh F. Galea-Lauri J, et al. Cancer Immunol Immunother. 2002 Aug;51(6):299-310. doi: 10.1007/s00262-002-0284-4. Epub 2002 Jun 14. Cancer Immunol Immunother. 2002. PMID: 12111118

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

314 results

Results by year